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Abstract
Meta-analysis of genome-wide association studies is increasingly popular and many meta-
analytic methods have been recently proposed. A majority of meta-analytic methods combine
information from multiple studies by assuming that studies are independent since individuals
collected in one study are unlikely to be collected again by another study. However, it has
become increasingly common to utilize the same control individuals among multiple studies
to reduce genotyping or sequencing cost. This causes those studies that share the same
individuals to be dependent, and spurious associations may arise if overlapping subjects are
not taken into account in a meta-analysis. In this paper, we propose a general framework for
meta-analyzing dependent studies with overlapping subjects. Given dependent studies, our
approach “decouples” the studies into independent studies such that meta-analysis methods
assuming independent studies can be applied. This enables many meta-analysis methods,
such as the random effects model, to account for overlapping subjects. Another advantage is
that one can continue to use preferred software in the analysis pipeline which may not support
overlapping subjects. Using simulations and the Wellcome Trust Case Control Consortium
data, we show that our decoupling approach allows both the fixed and the random effects
models to account for overlapping subjects while retaining desirable false positive rate and
power.
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Meta-analysis of genome-wide association studies is becoming increasingly popular [1,2]. Inves-
tigators combine multiple studies into a single meta-analysis to increase sample size and thereby
the statistical power to detect causal variants. In the past two to three years, large-scale meta-
analysis have been highly successful dramatically increasing the number of known associated
loci in many human diseases [3, 4].
There exist a number of categories of methods in meta-analysis. The fixed effects model (FE)
assumes that the effect sizes are fixed across the studies and is powerful when the assumption
holds [5,6]. The random effects model (RE) assumes that the effect sizes can be different between
studies, a phenomenon called heterogeneity [7]. A recently proposed random effects model is
shown to be more powerful than FE if the data are heterogeneous [8]. Additional categories
of methods include the p-value-based approaches [9, 10], the subset approaches assuming that
the effects are present or absent in the studies [11,12], and the Bayesian approaches [13–15]. A
majority of these methods combine information from multiple studies by assuming that studies
are independent since individuals collected in one study are unlikely to be collected again by
another study.
However, it has become increasingly common to utilize the same control individuals among
multiple studies to reduce genotyping or sequencing cost [16]. This causes those studies that
share the same individuals to be dependent, and spurious associations may arise if overlapping
subjects are not taken into account in a meta-analysis. A naive solution would be to manually
split the overlapping subjects into distinct studies, which can be sub-optimal [17] and may not
be practical if genotype data are not shared.
Recently, Lin and Sullivan proposed a meta-analytic approach that takes into account over-
lapping subjects [17]. This approach provides an optimal and elegant solution to account for
the correlation structure between studies caused by the overlapping subjects. However, their
method is exclusively based on the fixed effects model. Recent studies extended this method
to the p-value-based approach [10] and the subset approach [11], but to date, it is unclear
how to account for overlapping subjects in the random effects model and other meta-analytic
approaches.
In this paper, we propose a general framework for meta-analyzing dependent studies with
overlapping subjects, which is an extension of the Lin and Sullivan approach [17]. Given the
correlation structure between studies, the core idea is to uncorrelate or decouple the studies
into independent studies such that meta-analysis methods assuming independent studies can be
applied. The advantage of our decoupling approach is that it enables many meta-analysis meth-
ods, such as the random effects model, to account for overlapping subjects. Since our approach
3involves only the data-side change rather than the method-side change, one can continue to use
preferred software in the existing analysis pipeline which may not support overlapping subjects.
We analytically show that the Lin and Sullivan approach is one special case in our framework in
which the fixed effects model is applied after decoupling studies. We demonstrate the utility of
our approach by performing a meta-analysis of three autoimmune diseases using the Wellcome
Trust Case Control Consortium data [16].
2 Results
2.1 Overview of the Method
Many traditional as well as recently proposed meta-analytic methods exist, but a majority of
them cannot account for overlapping subjects (Table 1). Moreover, even if there exists a solution
for overlapping subjects in a specific method such as the fixed effects model, the software one
prefers may not support overlapping subjects. For example, widely used software METAL [18]
and MANTEL [2] do not support overlapping subjects. We propose a general framework that
allows different approaches to deal with overlapping subjects, which extends the Lin and Sullivan
approach [17]. Through this paper, we will often use the term “correlation of studies” to refer to
the correlation of statistics (typically z-scores) of studies in short. The intuition is that the more
studies are correlated, the less information they contain with respect to the summary statistic of
the meta-analysis. For example, if two studies are perfectly correlated (r = 1), their combined
information is not better than a single study’s information. In Figure 1, we have three studies
A, B, and C whose statistics are correlated. For simplicity, their variances are set to 1.0. Our
approach “decouples” the studies into independent studies that have the same information with
respect to the summary statistic. The penalty for the decoupling is the increased variances. The
variance of the study B has increased the most drastically (2.52), because its correlations to A
and C were large (0.5 and 0.3). The size of the circles denotes the amount of information in
terms of the inverse variance, showing that B has the smallest information. We can then use
the decoupled studies in the downstream meta-analysis method. If the downstream method is
the fixed effects model, our decoupling approach is equivalent to the optimal method of Lin and
Sullivan [17] (See Methods).
2.2 False positive rate and power simulations
We perform simulations to examine the false positive rate and power of our decoupling approach.
We suppose that ten different studies are combined in a meta-analysis to test a genotyped marker.
We make an assumption that the studies are uniform in their sample sizes and the marker
4allele frequencies. We also assume that the sample sizes are sufficiently large. Under these
assumptions, simulating genotype data is approximately equivalent to simulating the observed
effect sizes directly from a normal distribution. For simplicity, we assume that the variances
of effect sizes are uniformly 1.0. We use the significance threshold α = 0.05 for all simulations
below.
We first simulate the null model in which the marker is not associated with a disease in all
studies. We assume that the correlation rij between study i and j is uniform for all study pairs
i 6= j. This defines our covariance matrix Ω. Then we sample the vector of observed effect sizes
xˆ from N(0,Ω) 10,000 times. We vary rij from 0.0 to 0.9 and measure the false positive rates
for different meta-analytic approaches.
In Figure 2A, we compare the false positive rate of the methods for the fixed effects model.
The naive FE method refers to the traditional fixed effects model unaccounting for the cor-
relations. The naive method shows dramatically inflated false positive rate as expected, since
the correlations are ignored. The false positive rate becomes exacerbated as the unaccounted
correlation increases, up to 0.52 at rij = 0.9. The decoupling FE refers to our decoupling ap-
proach applying FE after decoupling the studies. Both the decoupling FE and the Lin-Sullivan
approach correctly control the false positive rate. The two methods yield the identical results,
since they are equivalent (See Methods). The average false positive rate of the two methods
over all correlation values rij was identically 0.050.
In Figure 2B, we assess the false positive rate of the methods for the random effects model.
The naive RE method refers to the Han and Eskin random effects model [8] unaccounting for
the correlation. The naive method shows dramatically inflated false positive rate that increases
with the correlation. The decoupling RE refers to our decoupling approach applying the Han
and Eskin random effects model [8] after decoupling the studies. The decoupling RE correctly
controls the false positive rate, with some conservative tendencies. The average false positive
rate of the decoupling RE over all correlation values rij was 0.034.
In Figure 2C, we simulate the alternative model assuming that the fixed effects model is the
generative model. We fix the correlation to be rij = 0.20. We sample xˆ from N(βe,Ω) where
we vary the mean effect β from 0.0 to 2.0. The decoupling FE shows power increase as the mean
effect increases. The power is identical to the Lin-Sullivan approach, since the two methods are
equivalent. Note that the naive FE method is not shown in the power comparison since its false
positive rate is not properly controlled.
In Figure 2D, we simulate the alternative model assuming that the random effects model
is the generative model. Again, we fix the correlation to be rij = 0.20. We sample xˆ from
N(βe,Ω + τ2I) where we vary both β and the heterogeneity τ2. The power of the decoupling
RE is shown for different configurations of the models. We find that the power shows typical
5characteristics of the random effects model; the power increases as the mean effect increases
and as the heterogeneity increases [8]. This shows that when we direct decoupled studies into
the random effects model, the method has power to detect alternative models that the random
effects model is designed for.
In summary, our simulations stress a few points; (1) The decoupling approach can be flexibly
applied to both the fixed and the random effects models. (2) When applied to the fixed effects
model, the decoupling approach shows equivalent results to the Lin-Sullivan approach. The
method accurately controls the false positive rate and shows power to detect the alternative
model. (3) When applied to the random effects model, the decoupling approach controls the
false positive rate with conservative tendencies, while retaining the power to detect alternative
models of the random effects model.
2.3 Applications to the Wellcome Trust Case Control Consortium data
We apply our decoupling approach to the Wellcome Trust Case Control Consortium (WTCCC)
data. The WTCCC has performed genome-wide association studies of seven diseases (bipolar
disorder, coronary artery disease, Crohn’s disease, hypertension, rheumatoid arthritis, type 1
diabetes, and type 2 diabetes, or BD, CAD, CD, HT, RA, T1D, and T2D in short). Using these
data, we perform meta-analysis of three autoimmune diseases (CD, RA, and T1D). These data
sets are a good example of overlapping subjects because all of the controls are shared between
diseases. The WTCCC performed a combined analysis using the genotype data of these three
diseases and reported four significant loci (See Supplementary Table 11 of Burton et al. [16]). We
want to show the utility of our approach by reproducing the same results only using summary
statistics without genotype data.
We first calculate the correlation matrix between the seven diseases using the Lin and Sullivan
formula (See equation (4) in Methods). Figure 3 shows that the studies are positively correlated
due to the shared control design. The correlations are at around r = 0.4 at all pairs of the
diseases. These uniform correlations reflects the unique study design that all controls are shared
and the similar numbers of cases are collected in all diseases.
We perform the meta-analysis of three autoimmune diseases (CD, RA, and T1D) using the
log odds ratios and their standard errors. We consider 397,450 SNPs that passed quality control
for all three diseases and the minor allele frequency is greater than 1%. We first apply the naive
fixed effects model (FE) and the random effects model (RE) which do not take into account the
correlation structure. Figure 4A shows that the qq-plot is highly inflated for both the naive FE
and the naive RE (the genomic control factors [19], λFE = 1.86 and λRE = 1.62, excluding the
MHC region). Since the p-values are highly inflated, further downstream analyses using these
naive approaches can be susceptible to false positives.
6We then apply our decoupling approach to account for the correlation structure. We con-
struct the decoupled studies and apply FE and RE. Figure 4B shows that the qq-plot is much
better calibrated (λFE = 1.05 and λRE = 0.82). Both the decoupling FE and RE approaches
identified the four loci as significant (P < 1.2 × 10−7, Bonferroni corrected for 397, 450 tests)
that were reported in the combined analysis of the WTCCC study [16] (Table 2). This shows
that our approach was able to reproduce the previously reported results only using the summary
statistics.
Moreover, our decoupling approach has an advantage over the combined analysis [16]. Since
our approach can utilize both FE and RE, one can have good power to detect both the homoge-
neous and the heterogeneous effects [8]. By contrast, the combined analysis can be thought of as
similar to FE and may not have good power to detect heterogeneous effects. In the Manhattan
plot (Figure 5), the notable peaks are the PTPN22 gene in the chromosome 1 and the major
histocompatibility complex (MHC) region in the chromosome 6. Both loci are known to play
an important role in autoimmune diseases [3, 4]. At both loci, the decoupling RE yields more
significant p-values than the decoupling FE (PTPN22 : PFE = 5× 10−23 and PRE = 1× 10−29,
MHC: PFE = 5× 10−80 and PRE = 8× 10−181). This is because of the heterogeneous nature of
these two loci that they are strongly associated to RA and T1D but weakly to CD (Table 2).
This shows that our decoupling approach can allow one to flexibly apply different meta-analytic
approaches that are optimized for different situations.
Finally, we examine the robustness of our decoupling approach by adding the other four dis-
eases as noisy data into the meta-analysis. Figure 5B shows that when we meta-analyze all seven
diseases, the absolute magnitudes of the significance of PTPN22 and MHC loci are reduced,
but they are still significant for both the decoupling FE and the decoupling RE. Moreover, the
relative significance gain of the decoupling RE compared to the decoupling FE is still largely
pronounced (PTPN22 : PFE = 1 × 10−11 and PRE = 9 × 10−18, MHC: PFE = 1 × 10−28 and
PRE = 1× 10−89).
3 Materials and Methods
3.1 Meta-analytic methods
We first briefly describe some of the existing meta-analytic methods.
Fixed effects model
The fixed effects model approach (FE) assumes that the magnitude of the effect size is fixed
across the studies [5, 6]. The two widely used methods are the inverse-variance-weighted effect
7size method [1] and the weighted sum of z-scores method [2]. Since the two methods are ap-
proximately equivalent [8], we only describe the inverse-variance-weighted effect size method.
Let X1, ..., XN be the effect size estimates in N independent studies such as the log odds ratios
or regression coefficients. Let SE(Xi) be the standard error of Xi and let Vi = SE(Xi)
2. Let
Wi = V
−1
i be the inverse variance. The inverse-variance-weighted summary effect size is
XFE =
∑
WiXi∑
Wi
. (1)
The variance of XFE is
VFE =
1∑
Wi
. (2)
Since the standard error of XFE is SE(XFE) =
√∑
Wi
−1
, we can construct a summary z-score
ZFE =
XFE
SE(XFE)
=
∑
WiXi√∑
Wi
that follows N(0, 1) under the null hypothesis of no associations. The p-value is calculated
pFE = 2Φ
(− |ZFE|)
where Φ is the cumulative density function of the standard normal distribution.
Random effects model
In the random effects (RE) model, it is assumed that the effect size varies among studies,
a phenomenon called heterogeneity. RE assumes that the effect size follows the probability
distribution with variance τ2. There are several approaches to estimate the variance τ2, the
most common one being the moment-based estimator of DerSimonian and Laird [7]. Given the
estimate (τˆ2) of τ2, the summary effect size estimate is calculated as
XRE =
∑(
W−1i + τˆ
2
)−1
Xi∑(
W−1i + τˆ2
)−1
The standard error ofXRE is SE(XRE) =
√∑(
W−1i + τˆ2
)−1−1
. In the traditional RE approach,
one constructs a z-score statistic
ZRE =
XRE
SE(XRE)
8and the p-value is computed as pRE = 2Φ
( − |ZRE |). Recently, Han and Eskin found that the
traditional RE is conservative and rarely achieves higher power than the fixed effects model [8].
This is because of the conservatie null hypothesis of the traditional RE that implicitly assumes
heterogeneity under the null. They proposed a new random effects model that corrects for this
problem, and the test statistic is
SNewRE =
∑
log
(
Vi
Vi + τˆ2
)
+
∑ X2i
Vi
−
∑ (Xi − µˆ)2
Vi + τˆ2
(3)
where µˆ and τˆ2 are the maximum likelihood estimations of mean and variance of the effect size,
respectively, which can be found by an iterative procedure. The statistic follows a half and
half mixture of χ2(0) and χ
2
(1) under the null [20]. The p-value can be calculated by using the
asymptotic distribution or using a pre-constructed p-value table for a more accurate calculation
accounting for the small number of observations [8].
P-value-based approaches
There exist meta-analytic approaches combining p-values instead of effect sizes, the most tradi-
tional one being the Fisher’s method [9]. The Fisher’s method combines the p-values p1, ..., pN
by constructing a statistic
SFisher = −2
N∑
i=1
log(pi)
which follows χ2(2N) under the null. The p-value-based approaches have advantages that it can be
used even when one does not have information about the direction of effects. A recently proposed
p-value-based approach by Zaykin and Kozbur can take into account overlapping subjects [10].
Subset approaches
Subset approaches have similarities to the fixed effects model, but the difference is that one
assumes that the effects can exist in only a subset of the studies. Han and Eskin computes
a statistic called “m-value”, a posterior probability that the effect is present in a study [12].
The m-values are incorporated in the weighted z-score FE approach to upweight studies with
high m-values. The p-value is assessed using the importance sampling. Bhattacharjee et al. [11]
proposed an approach that computes FE statistics using all possible subsets of studies in a
meta-analysis and uses the maximum statistic. The method expedites the enumeration of all
possible 2N −1 possible subsets of N studies by using a novel statistical technique. This method
can account for overlapping subjects.
9Bayesian approaches
Morris proposed a Bayesian approach optimized for the trans-ethnic meta-analysis [14]. This
method utilizes the Markov Chain Monte Carlo (MCMC) procedure to navigate through possible
disease models. In his MCMC, closely related populations have higher chance to have similar
effect sizes to increase the statistical power to detect heterogeneity caused by the population
spectrum. Wen [13] proposed a new method taking into account heterogeneity in the data using
the hierarchical model in the Bayesian framework. Wen [15] recently extended this method to
a multi-way table modeling, which can account for the correlation structure between studies or
the overlapping subjects.
3.2 Lin and Sullivan approach
Lin and Sullivan proposed a systematic approach for dealing with overlapping subjects for the
fixed effects model [17]. The first step of their approach is to analytically calculate the correlation
of the statistics X1, ..., XN caused by the overlapping subjects. Let x be the vector of effect size
estimates x = (X1, ..., XN ) and let
C =
[
rij
]
N×N
be the correlation matrix of X where rij denotes the the correlation between Xi and Xj . rij is
analytically approximated with the formula
rij ≈
(
nij0
√
ni1nj1
ni0nj0
+ nij1
√
ni0nj0
ni1nj1
)/√
ninj (4)
ni1, ni0, and ni (or nj1, nj0, and nj) are the number of cases, the number of controls, and the
total number of subjects in the ith (or jth) study, respectively. nij1 and nij0 are the numbers of
cases and controls that overlap between the ith and jth studies. See Bhattacharjee et al. [11] for
an extended formula for the situation that some cases in one study are controls in other studies.
Given the correlation matrix C, it is straightforward to calculate the covariance matrix Ω.
The second step of the Lin and Sullivan approach is to optimally take into account Ω in the
testing. The optimal fixed effects model meta-analysis statistic is
XLin =
eTΩ−1x
eTΩ−1e
(5)
where e is the vector of ones (e = (1, ..., 1)). The formal proof for the optimality of this statistic
is shown in [21] and [22]. We also present a simple reasoning for deriving this statistic in
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Supplementary Materials. The variance of the statistic is given
Var (XLin) =
1
eTΩ−1e
(6)
The z-score XLin/
√
Var (XLin) is calculated to obtain the p-value. Note that in a special case
that X1, ..., XN are independent (Ω is a diagonal matrix), XLin equals to XFE and Var (XLin)
equals to Var (XFE).
3.3 Decoupling approach
We extend the Lin and Sullivan approach to a general framework that can be applied to a wide
range of meta-analytic methods. Our approach “uncorrelates” or “decouples” correlated studies
into independent studies whose standard errors are updated to account for the decoupling.
Suppose that we are given the effect sizes x, the standard errors of them s, and the correlation
matrix C computed by the formula (4). The decoupling procedure is the following.
1. Keep the original x.
xDecoupled ← x
2. Compute the covariance matrix of x.
Ω← Diag(s) ·C ·Diag(s)
3. Compute the decoupled covariance matrix.
ΩDecoupled ← Diag(eTΩ−1)−1
4. Update the standard errors.
sDecoupled[i]←
√
ΩDecoupled[i, i] for each i = 1, ..., N
5. Use xDecoupled and sDecoupled in the downstream meta-analysis.
Diag(s) denotes a diagonal matrix whose diagonals are s. The brakets [ ] denote the index of
an element of a vector or a matrix. In Supplementary Materials, we present a simple R code
performing this procedure.
We give a simple working example of this procedure. Suppose that we have two effect sizes
X1 and X2. For simplicity, let their variances be 1.0. Under the fixed effects model, the best
summary estimate of effect size will be (X1 +X2)/2 and its variance will be 1.0/2 = 0.5, which
will be the correct variance if the two studies are independent (r12 = 0). Now consider the case
that X1 and X2 are highly correlated (r12 = 0.99). Intuitively, since they are highly correlated,
the information they contain is not much better than the information a single study contains.
The decoupling formula gives us the new variance of each study increased to 1.99. When we
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plug the new variances into the fixed effects model, the variance of the summary effect size
will be 1.99/2 = 0.995 ≈ 1.0 showing that as expected, the uncertainty in the final estimate is
approximately the same as the uncertainty that we would obtain with a single study.
Observation 1. Using the decoupled studies in the fixed effects model is equivalent to the Lin
and Sullivan approach.
Proof. Given a covariance matrix Ω, our decoupling approach will calculate the updated stan-
dard errors sDecoupled by calculating ΩDecoupled. Since ΩDecoupled is a diagonal matrix, the
following relationship holds
ΩDecoupled = Diag(sDecoupled) ·Diag(sDecoupled)
On the other hand, given an effect size vector x and standard errors s, the standard fixed effects
model formulae in equation (1) and (2) can be written
XFE =
eTV−1x
eTV−1e
and
VFE =
1
eTV−1e
where V = Diag(s) ·Diag(s). If we plug sDecoupled into this formula,
XFE =
eTV−1x
eTV−1e
=
eT (Diag(sDecoupled) ·Diag(sDecoupled))−1x
eT (Diag(sDecoupled) ·Diag(sDecoupled))−1e
=
eTΩ−1Decoupledx
eTΩ−1Decouplede
=
eTDiag(eTΩ−1)x
eTDiag(eTΩ−1)e
=
eTΩ−1x
eTΩ−1e
= XLin
where XLin is in equation (5). Similarly, we can show that VFE equals to VLin in equation (6).
Therefore, applying our decoupling approach to the fixed effects model is equivalent to the Lin
an Sullivan approach [17].
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4 Discussions
We proposed a general framework for dealing with overlapping subjects in a meta-analysis. The
core idea is to “decouple” the correlated studies into independent studies and use them in the
downstream meta-analysis. Our approach can flexibly allow many meta-analytic methods, such
as the random effects model, to account for overlapping subjects. The simulations and the
applications to the WTCCC data support the utilities of our approach.
Since our approach involves only the data-side change rather than the method-side change,
one advantage is that one can continue to use preferred software in the existing analysis pipeline
which may not support overlapping subjects. This can be important in practice, since it can
be inconvenient to change a pipeline. For example, one may have been using METAL [18] or
MANTEL [2] for automatically detecting strand inconsistencies between studies and for auto-
matically applying the genomic control [19]. Given new data with overlapping subjects, one
does not need to switch to different software supporting overlapping subjects but can simply
update the standard errors using our approach and continue to use the existing pipeline.
In this paper, we primarily focused on dealing with overlapping subjects, but our decoupling
approach can be applied to any contexts of meta-analysis where the inputs are correlated.
For example, in an eQTL study, multiple tissues can be analyzed together in a meta-analysis
framework [23]. Since tissues of the same individual are correlated, this results in a meta-analytic
problem where the inputs are correlated. In such cases, our decoupling approach with FE and
RE methods can be applied to detect both tissue-specific and shared eQTLs [23].
The limitation of our approach is that the optimality is guaranteed only under the fixed
effects model. For example, our simulations show that our approach has some conservative
tendencies under the random effects model, indicating that our approach may not be optimal,
although we showed that it works well in the simulations and the WTCCC data. Optimal
solutions to account for correlated inputs for each different meta-analytic method will be an
interesting topic for further research.
We note that one should be careful in interpreting data based on the decoupled studies. For
example, the heterogeneity testing is highly conservative when using decoupled studies and may
not well detect true heterogeneity. Unfortunately, there is no good alternative to the Cochran’s
Q test and the I2 estimate that can take into account correlated inputs yet. Developing such
methods will also be an interesting future research area.
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5 Tables and Figures
Category Method Supports overlapping subjects
Fixed effects model Traditional FE [5,6] No
Lin and Sullivan [17] Yes
Random effects model Traditional RE [7] No
Han and Eskin RE [8] No
P-value-based approaches Fisher’s approach [9] No
Zaykin and Kozbur [10] Yes
Subset approaches Bhattacharjee et al. [11] Yes
Binary Effects Model [12] No
Bayesian approaches Hierarchical Bayesian approach [13] No
Trans-ethnic approach [14] No
Multi-way table approach [15] Yes
Table 1: Different meta-analytic methods and their support for overlapping subjects.
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Figure 1: A simple example of our decoupling approach. Ω and ΩDecoupled are the covariance
matrices of the statistics of three studies A, B, and C before and after decoupling respectively.
The thickness of the edges denotes the amount of correlation between the studies. After de-
coupling, the size of the nodes reflects the information that the studies contain in terms of the
inverse variance.
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Figure 2: The false positive rate and power of different methods under the fixed and the random
effects model. (A, B) We simulate studies assuming the null model of no associations. (C) We
simulate studies assuming the alternative model based on the fixed effects model where the effect
sizes are fixed across studies. We vary the magnitude of the fixed effect size. (D) We simulate
studies assuming the alternative model based on the random effects model where the effect sizes
vary across studies with an additional variance τ2. We vary both the magnitude of the mean
effect size and the heterogeneity τ2.
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Figure 3: The correlation structure of the statistics of seven diseases in the WTCCC data. All
seven diseases have approximately 2,000 cases and share 2,938 controls.
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Figure 4: The qq-plots of a meta-analysis combining CD, RA, and T1D of the WTCCC data.
The MHC region is excluded.
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Figure 5: The Manhattan plots of meta-analyses combining a set of diseases of the WTCCC
data. (A) We combine CD, RA, and T1D. (B) We combine all seven diseases.
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6 Supplementary Materials
6.1 Optimality of Lin and Sullivan approach
We present a simple reasoning to derive and show the optimality of the Lin and Sullivan statistic
in equation (5). Note that the formal proof of the optimality is shown in [22] and [21], and there
can be many other proofs. The equation (5) is
XLin =
eTΩ−1x
eTΩ−1e
where the notations are described in Methods. One simple way to derive this statistic is to
translate the problem of finding a summary statistic to a linear regression framework. Consider
that x is the dependent variables whose variance is Ω. Then finding the best summary statistic
is equivalent to finding the best mean or the intercept β. Thus, we have a regression model
including only the intercept term
x = βe + 
where Var () = Ω. By the standard generalized least square formula, the optimal estimate of β
will be
βˆ = (eTΩ−1e)−1eTΩ−1x
Since eTΩ−1e is a scalar, this form is equivalent to XLin.
6.2 R code performing decoupling approach
## Decoupling approach.
## Input:
## s is the standard errors (possibly with NA)
## C is the correlation matrix
## (or one can specify C.inv (inverse of C) for speed-up)
## Output:
## updated standard errors after decoupling
decoupling <- function(s, C, C.inv=NULL) {
i <- !is.na(s)
if (is.null(C.inv)) {
Omega.inv <- solve(diag(s[i]) %*% C[i,i] %*% diag(s[i]))
} else {
Omega.inv <- diag(1/s[i]) %*% C.inv[i,i] %*% diag(1/s[i])
}
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s.new <- sqrt(1/rowSums(Omega.inv))
s[i] <- s.new
s
}
